High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Roger Stupp(Northwestern University), George Pentheroudakis(Hellenic Cooperative Oncology Group)

Annals of Oncology

April 30, 2014

10.1093/annonc/mdu050

Cited by 760

Related Papers

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

|New England Journal of Medicine|2005|7.2k

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

|JAMA|2017|2.5k

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

|Journal of Clinical Oncology|2013|1.1k

Correlation of O<sup>6</sup>-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

|Journal of Clinical Oncology|2008|805

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

|Annals of Oncology|2017|591